Nxera Pharma
4565.TPharmaceutical
Filed as Sosei Group Corporation (2022-08–2024-03)
Major holders (5%+) · 1
| Holder | Stake |
|---|---|
| Gomi Daisuke | 11.67% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 19
| Taiyo Pacific Partners L.P. | 4.80% |
| Nomura Asset Management Co., Ltd. | 3.34% |
| Goldman Sachs International | 3.28% |
| Mizuho Securities Co., Ltd. | 3.27% |
| J.P. Morgan Securities LLC | 2.54% |
| Asset Management One Co., Ltd. | 2.07% |
| Capital Research and Management Company | 2.06% |
| J.P. Morgan Securities plc | 1.76% |
| Capital International K.K. | 1.51% |
| Mizuho Trust & Banking Co., Ltd. | 1.29% |
| NOMURA INTERNATIONAL PLC | 0.80% |
| J.P. Morgan Prime Inc. | 0.36% |
| Capital International, Inc. | 0.33% |
| Capital International Sarl | 0.30% |
| Capital Group Investment Management Pte. Ltd. | 0.14% |
| Nomura Securities Co., Ltd. | 0.09% |
| Goldman Sachs Japan Co., Ltd. | 0.02% |
| JPMorgan Securities Japan Co., Ltd. | 0.01% |
| Mizuho International plc | 0.00% |
Ownership history · 45
| Holder | Ratio | Change |
|---|---|---|
| Capital International Sarl2024-02-22 · amended | 0.30% | new |
| Capital International, Inc.2024-02-22 · amended | 0.33% | new |
| Capital International K.K.2024-02-22 · amended | 1.51% | new |
| Capital Research and Management Company2024-02-22 · amended | 2.06% | new |
| Taiyo Pacific Partners L.P.2024-01-19 · amended | 7.12% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.